Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Other financing activities (2016 - 2024)

Historic Other financing activities for Tg Therapeutics (TGTX) over the last 4 years, with Q4 2024 value amounting to $31000.0.

  • Tg Therapeutics' Other financing activities changed N/A to $31000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $889000.0, marking a year-over-year increase of 61120.0%. This contributed to the annual value of $889000.0 for FY2024, which is 61120.0% up from last year.
  • According to the latest figures from Q4 2024, Tg Therapeutics' Other financing activities is $31000.0.
  • In the past 5 years, Tg Therapeutics' Other financing activities registered a high of $858000.0 during Q3 2024, and its lowest value of $31000.0 during Q4 2024.